Nahdi Medical Company (4164.SR)
SAR 114.2
(-0.17%)
SAR 114.2
(-0.17%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.37 Billion SAR | 8.62% |
| 2022 | 4.94 Billion SAR | 15.35% |
| 2021 | 4.28 Billion SAR | -8.12% |
| 2020 | 4.66 Billion SAR | 11.45% |
| 2019 | 4.18 Billion SAR | 55.7% |
| 2018 | 2.68 Billion SAR | 4.56% |
| 2017 | 2.57 Billion SAR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 5.75 Billion SAR | 1.47% |
| 2024 Q1 | 5.67 Billion SAR | 5.66% |
| 2023 Q2 | 5.21 Billion SAR | -7.87% |
| 2023 Q1 | 5.65 Billion SAR | 14.41% |
| 2023 FY | 5.37 Billion SAR | 8.62% |
| 2023 Q4 | 5.37 Billion SAR | 4.69% |
| 2023 Q3 | 5.13 Billion SAR | -1.56% |
| 2022 Q4 | 4.94 Billion SAR | -0.5% |
| 2022 Q3 | 4.96 Billion SAR | -1.25% |
| 2022 Q2 | 5.03 Billion SAR | 2.94% |
| 2022 Q1 | 4.88 Billion SAR | 14.04% |
| 2022 FY | 4.94 Billion SAR | 15.35% |
| 2021 FY | 4.28 Billion SAR | -8.12% |
| 2021 Q3 | 4.36 Billion SAR | -9.29% |
| 2021 Q2 | 4.81 Billion SAR | 0.0% |
| 2021 Q1 | - SAR | -100.0% |
| 2021 Q4 | 4.28 Billion SAR | -1.9% |
| 2020 Q1 | - SAR | 0.0% |
| 2020 FY | 4.66 Billion SAR | 11.45% |
| 2020 Q4 | 4.66 Billion SAR | 0.0% |
| 2019 FY | 4.18 Billion SAR | 55.7% |
| 2018 FY | 2.68 Billion SAR | 4.56% |
| 2017 FY | 2.57 Billion SAR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Middle East Pharmaceutical Industries Co. | 444.89 Million SAR | -1107.315% |
| Al-Dawaa Medical Services Company | 4.7 Billion SAR | -14.102% |
| Al-Razi Medical Co. | 45.41 Million SAR | -11726.537% |
| Almujtama Alraida Medical Co. | 441.99 Million SAR | -1115.24% |